The advent of mRNA vaccines against SARS-CoV-2 in 2020 changed the course of the COVID-19 pandemic. Now, the Nobel ...
Mayo Clinic scientists are exploring an unusual but promising strategy to treat one of the deadliest bile duct cancers by turning milk into a microscopic delivery system for gene therapy. Their work ...
Keytruda drug is approved for a wide range of solid tumors and blood cancers, often for cases that are advanced, metastatic ...
Phio invites investors, advisors and analysts with an interest in the life sciences sector to attend this virtual eventR.
Verrica Pharmaceuticals Inc. ("Verrica") (Nasdaq: VRCA), a therapeutics company developing and commercializing medications for the treatment of dermatological ...
Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a therapeutics company developing and commercializing medications ...
Zacks Small Cap Research on MSN

HURA: 2025 financial results

By John Vandermosten, CFA NASDAQ: HURA READ THE FULL HURA RESEARCH REPORT Operational and Financial Results On April 1st, ...
- Zynyz ® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) is the first systemic treatment for adult patients with advanced SCAC in Europe - The EC approval ...
ABSTRACT: Merkel cell carcinoma (MCC) is a rare and aggressive cutaneous neuroendocrine tumor predominantly affecting elderly and immunocompromised patients. It is characterized by a high propensity ...
Spots, bumps or patches that suddenly appear on your skin can be alarming, especially if they grow quickly, become red or irritated, or do not seem to heal. It can be difficult to tell whether it is ...